Skip to main content

Advertisement

We're creating a new version of this page. See preview

  • Research article
  • Open Access

Interplay between the heterotrimeric G-protein subunits Gαq and Gαi2 sets the threshold for chemotaxis and TCR activation

BMC Immunology200910:27

https://doi.org/10.1186/1471-2172-10-27

©  Ngai et al; licensee BioMed Central Ltd. 2009

  • Received: 10 November 2008
  • Accepted: 08 May 2009
  • Published:

Abstract

Background

TCR and CXCR4-mediated signaling appears to be reciprocally regulated pathways. TCR activation dampens the chemotactic response towards the CXCR4 ligand CXCL12, while T cells exposed to CXCL12 are less prone to subsequent TCR-activation. The heterotrimeric G proteins Gαq and Gαi2 have been implicated in CXCR4-signaling and we have recently also reported the possible involvement of Gαq in TCR-dependent activation of Lck (Ngai et al., Eur. J. Immunol., 2008, 38: 32083218). Here we examined the role of Gαq in migration and TCR activation.

Results

Pre-treatment of T cells with CXCL12 led to significantly reduced Lck Y394 phosphorylation upon TCR triggering indicating heterologous desensitization. We show that knockdown of Gαq significantly enhanced basal migration in T cells and reduced CXCL12-induced SHP-1 phosphorylation whereas Gαi2 knockdown inhibited CXCL12-induced migration.

Conclusion

Our data suggest that Gαi2 confers migration signals in the presence of CXCL12 whereas Gαq exerts a tonic inhibition on both basal and stimulated migrational responses. This is compatible with the notion that the level of Gαq activation contributes to determining the commitment of the T cell either to migration or activation through the TCR.

Keywords

  • Chemokine Receptor CXCR4
  • CXCR4 Signaling
  • Reciprocal Regulation
  • Heterologous Desensitization
  • CXCR4 Surface Expression

Background

Chemokines dictate the migration and positioning of leukocytes at steady-state and in inflammation [1]. The chemokine CXCL12, also known as stromal cell-derived factor-1α (SDF-1α), is a member of the CXC chemokine subfamily and serves as the only known ligand for the chemokine receptor CXCR4 expressed on most leukocytes [1–3]. Mice lacking CXCL12 or CXCR4 die perinatally of cardiovascular, neurologic, vascular, and hematopoietic defects [4, 5]

The CXCR4 receptor is a G-protein coupled receptor (GPCR) and couples to heterotrimeric G-proteins of both the Gαi and Gαq-families [6–8]. Members of the Gαi-family of G-proteins are pertussis toxin sensitive and pre-treatment of cells with pertussis toxin severely attenuates chemotaxis in response to chemokines. Gαi-proteins are therefore thought to be essential for chemokine-mediated migration. Of the Gαi-family, Gαi2 and Gαi3 are strongly expressed by lymphocytes [9]. Gαi3-/- mice are without phenotype [10] whereas Gαi2-/- mice display dysfunctional T cell functions as well as defective chemotaxis in response to chemokines [6]. In contrast, Gαq has been shown to be required for chemotaxis of dendritic cells and granulocytes, but not for T cells [7].

Stimulation of the T cell receptor (TCR), the B cell receptor, or the Ly49D activating receptor all reduce lymphocyte migration toward CXCL12 [11–14] suggesting that cells dedicated to proliferation/differentiation are less sensitive towards chemokines. The opposite is also true, as cells exposed to CXCL12 show less phosphorylation of ZAP-70 and LAT following subsequent TCR activation indicating reciprocal regulation between CXCR4 and the TCR [13]. In addition, recruitment of chemokine receptors into the immunological synapse has been shown to stabilize T cell-APC interaction through activation of a Gαq-dependent pathway. This renders the cell less responsive to chemotactic gradients and gives higher T cell proliferative responses and cytokine production [8]. Recently, the TCR and CXCR4 were shown to closely associate upon CXCL12-stimulation [15], and it was suggested that CXCR4 signaling occurs through the immunoreceptor tyrosine-based activation motif (ITAM)-domain present in the CD3ζ chain. Collectively, these results point to a direct crosstalk between the signaling machineries utilized by the TCR and CXCR4.

We have recently shown that Gαq knockdown in T cells inhibits the activation of the Src family kinase Lck [16]. The effect of Gαq on Lck activation might be conferred by a direct interaction and/or by affecting the threshold for TCR-triggering. We demonstrate here that knockdown of Gαq significantly enhances basal T cell migration while inhibiting TCR-induced Lck activation. Pre-treating cells with CXCL12 prior to stimulation with anti-CD3 leads to a similar inhibition of Lck activation indicating that cells directed to migrate are less responsive to TCR triggering. The signals conveyed by Gαq appear to be mediated through a SHP-1 pathway. Our data suggest that optimal TCR activation requires signaling through Gαq, and that removal of Gαq locks the cell in migration modus making the cell less responsive to TCR signaling

Methods

Antibodies and reagents

Human recombinant CXCL12 was obtained from Invitrogen (cat. no. PHC1344) and Peprotech (Rocky Hill, NJ). Antibody to Gαi2 was from Calbiochem (cat. no. 371727). Antibodies against SH-PTP1, Gαq, Lck, Protein A/G Plus Agarose beads and SH-PTP1 conjugated agarose beads were purchased from Santa Cruz (cat. no. sc-287, cat. no. sc-393, cat. no. sc-433, cat. no. sc-2003, cat. no. sc-287 AC). Antibodies against phospho-p44/42 MAPK (Thr202/Tyr204) and Src pY416 (detecting also Lck pY394) were obtained from Cell Signaling (cat. no. 9106 and cat. no. 2101). Anti-phosphotyrosine mAb (4G10) was purchased from Upstate (cat. no. 05-777). Peroxidase-conjugated secondary antibodies and Affinipure F(ab')2 fragment Goat Anti-Mouse IgG were obtained from Jackson ImmunoResearch Laboratories (cat. no. 111-035-144, cat. no. 115-035-146, cat. no. 115-006-072). Anti-CXCR4-PE was obtained from BD Pharmingen (cat. no. 555974).

siRNA design

21-nt siRNA duplexes targeting human Gαq mRNA (NM_002072) (GNAQ-1103; 5'-GGAGUACAAUCUGGUCUAAUU-3'; 5'-UUAGACCAGAUUGUACUCCUU-3') and a triple G/C switch control (GNAQ-1103M3; 5'-GCAGUAGAAUCUGCUCUAAUU-3'; 5'-UUACACCACAUUGUAGUCCUU-3'); Gαi2 mRNA (NM_002070.1) (GNAI-1050; 5'-GGACCUGAAUAAGCGCAAAGA-3'; 5'-UUUGCGCUUAUUCAGGUCCUC-3') were designed and synthesized in-house. The oligos are named according to the position of the 5' nucleotide of the sense strand relative to the reference sequences. For a detailed characterization of the effect of these siRNAs, see Ngai et al. [16].

Cell culture and transfections

The Jurkat TAg T cell line stably transfected with SV40 large T antigen was kept in logarithmic growth in RPMI-1640 (Invitrogen) supplemented with 10% FCS, 1% Penicillin-Streptomycin, 1% Non-essential amino acids and 1% Sodium Pyruvate. 20 × 106 cells were washed and resuspended in 400 μl OptiMEM (Invitrogen), mixed with cDNA or siRNA and electroporated in 0.4 cm electroporation cuvettes (Bio-Rad) at 250 V/cm and 975 μF. Cells were harvested 48 hours post transfection.

Cell stimulation and lysis

Cells were resuspended in RPMI 1640 to 50 × 106/ml and pre-incubated at 37°C for 5 minutes. Cells were then stimulated with 100 ng/ml CXCL12 or 1.5 μg/ml OKT3 for the indicated time points and the reaction was subsequently stopped by lysis in ice cold lysis buffer (50 mM HEPES, 100 mM NaCl, 5 mM EDTA, 50 mM NaF, 10 mM Na-pyrophosphate, 1 mM Na3VO4, 1 mM PMSF, 1.0% Triton X-100). Where indicated, cells were pre-treated with 100 ng/ml CXCL12 or 10 μM PP2 for 30 minutes at 37°C prior to stimulation. Samples were spun down at 13 000 rpm for 10 min and the supernatant boiled with SDS-buffer, subjected to SDS-PAGE and transfered to PVDF filters. Filters were subjected to immunoblotting with the indicated antibody over night at 4°C, washed 3 × 10 minutes with TBS-T, incubated 45 minutes with secondary antibody at RT, washed 3 × 10 minutes with TBS-T before incubation with SuperSignal West Pico Chemiluminescent Substrate for 5 minutes.

Intracellular Ca2+ measurement

Cells were resuspended to 107 cells/ml in PBS w/1% BSA and incubated with 4 μg/ml Fluo-4 AM and 10 μg/ml Fura Red AM for 30 minutes at 30°C. Cells were spun down and resuspended to 3 × 107 cells/ml in PBS w/1% BSA. Cells were stimulated with 100 ng/ml CXCL12 and Ca2+ levels were measured by flow cytometry.

Migration assay

Migration assays were performed in 24-well plates with 5.0 μm pore-sized polycarbonate membrane inserts (Costar Transwell, Cat. no. CLS-3421). Cells were washed in RPMI-1640 supplemented with 2% FCS and 25 mM Hepes (chemotaxis medium) and resuspended to 1 × 106 cells/ml. Six hundred μl chemotaxis medium was added to wells with or without 10 ng/ml CXCL12. Cells (1.5 × 105) were loaded into the transwell inserts and allowed to migrate for 2 hrs at 37°C and 5% CO2. Cells that had passed through the filter into the lower chamber were collected and 10 μl of an internal bead control (Bangs Laboratories, Fishers, IN) was added. The cells were counted by flow cytometry (FACS Calibur, Becton Dickinson) and normalized with reference to the internal bead control. Migration index was calculated as the number of cells migrating towards CXCL12 in the test well relative to the number of unmanipulated cells migrating towards medium in the control wells.

CXCR4 surface expression

Forty-eight hours post-transfection, Jurkat T cells were stimulated with 100 ng/ml CXCL12 for different time points, washed in ice-cold PBS, fixed in 4% paraformaldahyde for 10 minutes at 37°C, washed in PBS, and resuspended in PBS w/1% BSA and anti-CXCR4-PE for 30 min at 4°C. Thereafter the cells were washed in PBS w/1% BSA and subjected to flow cytometric analysis for detection of surface CXCR4 expression.

Statistical analysis

All data are representative of at least three different experiments. Values are expressed as mean ± S.E.M as indicated in the figures. Statistical analysis was performed with Student's t-test.

Results and Discussion

CXCL12-pretreatment attenuates TCR-induced Lck activation comparable to the Gαq-kd-kd phenotype

We have previously shown that siRNA-mediated knockdown of the heterotrimeric G protein Gαq in T cells attenuates TCR-induced Lck activation [16]. While the TCR is not thought to be directly associated with G proteins, the chemokine receptor CXCR4 can couple to both Gαq and Gαi2. Furthermore, CXCR4 has been shown to associate with TCR upon CXCL12 activation [15]. Activation of tyrosine kinases by Gα-subunits has been demonstrated [17–20] and could represent the mechanism by which CXCR4 activates Lck [21]. We show here that the Src family kinase inhibitor, PP2, abrogated CXCL12-induced tyrosine-phosphorylation of several proteins (Figure 1A, marked with *), a further indication that Src family kinases act downstream of CXCR4. However, the changes in tyrosine phosphorylation following CXCL12 treatment are modest compared to those of anti-CD3 treatment (data not shown). Furthermore, pre-treatment of Jurkat T cells with CXCL12 prior to stimulation with anti-CD3 attenuated TCR-induced Lck activation (Figure 1B). Similarly, we also observed reduced ZAP-70 phosphorylation in cells pre-stimulated with CXCL12 (Figure 1B). This is in line with a previous report showing reduced TCR-induced phosphorylation of ZAP-70 and LAT in CXCL12-pretreated cells [13] suggesting that post-activation heterologous desensitization is occurring possibly as a result of Gαq sequestration. Consistent with this notion surface expression of CXCR4 was also down after 30 minutes incubation with CXCL12. To address the role of Gα-subunits in controlling the switch between TCR and CXCR4-signaling events, we subjected Jurkat T cells to siRNAs against Gαq or Gαi2. We achieved more than 90% knockdown with these siRNAs as analysed by Western blotting (Fig. 1C). As previously demonstrated [16] TCR-induced Lck Y394 autophosphorylation was reduced in Gαq-knockdown but not Gαi2-knockdown T cells demonstrating that Gαq may directly or indirectly activate Lck (Fig 1C).
Figure 1
Figure 1

CXCL12-pretreatment attenuates TCR-induced Lck activation. (A) Jurkat TAg T cells were incubated with or without 10 &#956M PP2 for 30 minutes at 37°C prior to stimulation with CXCL12 (100 ng/ml) for the indicated time-points and stopped with lysis buffer. Cell lysates were subjected to immunoblotting with the indicated antibodies. (B) Jurkat TAg T cells were incubated with 100 ng/ml CXCL12 for 30 minutes at 37°C prior to stimulation with OKT3 (1.5 μg/ml) for the indicated time-points and stopped with lysis buffer. Cell lysates were subjected to immunoblotting with the indicated antibodies. Cells were also stained with anti-CXCR4 and surface expression of the receptor was analysed by flow cytometry. (C) Jurkat TAg T cells were transfected with Gαq-specific siRNA (GNAQ1103), Gαi2-specific siRNA (GNAI-2-1050) or control siRNA (GNAQ1103 M3). 48 hours post-transfection cells were stimulated with OKT3 (1.5 μg/ml) for the indicated time-points and stopped with lysis buffer. Cell lysates were subjected to immunoblotting with the indicated antibodies. All figures are representative of at least 3 independent experiments.

Gαq-kd sets the threshold for chemotaxis

The reciprocal regulation between the TCR and chemokine receptors [13, 22, 23] suggest that the response to a specific chemokine is determined both by the differentiation and the activation state of the responding T cell. This implies that migrating T cells are less responsive to activation through the TCR. The physiological relevance of this switch between migration modus and TCR activation modus may be to ensure that migrating T cells do not get distracted by activation cues until they reach their destination. Conversely, TCR triggered T cells are less responsive to chemotactic gradients to ensure optimal activation. We observed that knockdown of Gαq enhanced basal migration 2-fold (Figure 2A), suggesting that Gαq may set the threshold for directed migration. This supports the findings of Molon et al. [8] who speculated that CXCR4 signaling through Gαq promoted adhesion instead of migration. Accordingly, we saw that knockdown of Gαi2 inhibited directed CXCL12-induced migration, while Gαq knockdown had no effect (Figure 2A) confirming the notion that Gαi2 is the principal Gα-subunit involved in chemotaxis. The inhibitory effect of Gαi2 knockdown could however be partly reversed with simultaneous knockdown of Gαq (Figure 2A). We speculate that the presence of Gαq and absence of Gαi2 may result in a combined strong inhibitory effect on chemotaxis. Removal of Gαq, will then lead to partial release of the inhibitory effect of Gαi2 knockdown alone. Although T cells from Gαq-/- mice show no migrational defects [7], data from knockout mice are difficult to interpret as compensatory mechanisms may have been established during development. Acute knockdown with siRNA provides an alternative method to examine protein functions. How CXCR4 switches its signaling through Gαi2 and Gαq is unknown, but the level of TCR engagement has been implicated [8, 13]. Surface expression of CXCR4 following CXCL12-stimulation was neither affected by knockdown of Gαq nor Gαi2 during a 1-hour time course (Figure 2B, only 0 minutes and 30 minutes shown). The level of surface expression of CD3 on Jurkat Tags has recently been reported [24]. Furthermore, we suggest that neither Ca2+-elevation nor ERK1/2 phosphorylation are involved in chemotaxis as has been suggested in a previous report [7]. While elevation of intracellular Ca2+ was abrogated in the Gαq-knockdown cells upon CXCR4-stimulation (Figure 2C), it was intact in Gαi2-knockdown cells. The level of ERK1/2 phosphorylation was similar in both Gαq-knockdown and Gαi2-knockdown Jurkat cells. However, concomitant knockdown of both Gαq and Gαi2 completely attenuated ERK1/2 phosphorylation (Figure 2D), indicating that this is a G-protein dependent event.
Figure 2
Figure 2

Gαq and Gαi2 have opposing roles in chemotaxis. (A) Jurkat TAg T cells were transfected with Gαq-specific siRNA (GNAQ1103), Gαi2-specific siRNA (GNAI-2-1050) or control siRNA (GNAQ1103 M3). 48 hours post-transfection cells were placed in Costar Transwell wells with/without 10 ng/ml CXCL12. After 2 hours incubation the numbers of migrated cells were counted by flow cytometry Migration index was calculated as the number of cells migrating divided by the number of basal migrating mock tx cells (n = 8). (B) Cells were subjected to transfection as in (A). 48 hours post-transfection cells were stimulated with CXCL12 for the indicated time points. Cells were stained with anti-CXCR4 and surface expression of the receptor was analysed by flow cytometry (n = 3). (C) Cells were subjected to transfection as in (A). 48 hours post-transfection cells were stained with Fluo-4 and Fura Red AM and calcium fluxes were measured by flow cytometry. Grey lines indicates CXCL12 stimulated cells, black line unstimulated cells. Representative of 3 independent experiments. (D) Cells were subjected to transfection as in (A). 48 hours post-transfection cells were stimulated with CXCL12 for the indicated time points, lysed and subjected to immunoblot analysis with the indicated antibodies. Levels of immunoreactive protein were quantified by densitometric scanning from 3 independent experiments and normalized against total protein (Mean ± S.E.M.).

The Gαi2-kd-signaling pathway dominates the CXCL12-induced migrational response

To test whether the Gαi2-signaling pathway is the principal pathway activated by CXCR4 we pre-treated cells with the PI3K inhibitor wortmannin prior to incubation with CXCL12. In the presence of wortmannin CXCL12-induced migration was strongly inhibited (Figure 3A vs Figure 2A). Furthermore, in the presence of wortmannin the Gαq-kd cells displayed an approximately 80% increase in CXCL12-induced migration (Figure 3A). This suggests that the negative regulatory effect of Gαq on migration is normally not observed when the Gαi2 signaling pathway through PI3K is intact, and that a switch from Gαi2 to Gαq is necessary to fully inhibit migration. These observations correlate well with the data showing that co-knockdown of Gαq and Gαi2 has a smaller inhibitory effect on migration than knockdown of Gαi2 alone (Figure 2A). Although the presence of Lck is shown to be necessary for migration [21] activating Lck through the TCR receptor has an inhibitory effect on migration [13]. Consistent with these findings cells transfected with the constitutively active Lck Y505F showed a significant inhibition of migration compared to vector-transfected cells (Figure 3B). Interestingly, the effect of Gαq-kd on wortmannin-treated T cells in the presence of CXCL12 is reversed when transfected with Lck Y505F indicating that the effect of Gαq is mediated through Lck (Figure 3C).
Figure 3
Figure 3

CXCL12 stimulation primarily activates Gαi2.(A) Jurkat TAg T cells were tranfected with G-specific siRNA (GNAQ1103), Gαi2-specific siRNA (GNAI-2-1050) or control siRNA (GNAQ1103 M3). 48 hours post-transfection cells were pre-treated with Wortmannin for 30 minutes and analyzed for CXCL12 dependent and independent migratory responses. Migration index represents fold migration over basal in control cell wells. (B) Jurkat TAg T cells were transfected with Lck Y505F or empty vector migration was analysed in the absence and presence of CXCL12 (10 ng/ml). Migration index represents fold increase in migration over basal migration in wells with control cells. (C) Cells were subjected to tranfection as in (B) pre-treated with Wortmannin as in (A) and migration with CXCL12 was analysed. Migration index represents fold increase in migration over basal migration in wells with control cells.

Gαq-kd inhibits migration through activation of SHP-1

Src homology phosphatase-1 (SHP-1) is an Lck-activated tyrosine phosphatase reported to negatively regulate CXCL12-induced migration [25]. As we have recently reported that Gαq may activate Lck we examined how Gαq manipulation would affect SHP-1 regulation in migration. Knockdown of Gαq resulted in decreased tyrosine phosphorylation of SHP-1 compared to control cells (Fig 4A and 4B). This may indicate a role for Gαq in the activation of SHP-1. Interestingly, increased basal phosphorylation of SHP-1 was observed in Gαi2 knockdown cells. This may be due to skewing of the CXCR4 signaling pathway towards Gαq as there is less Gαi2 available. Conversely, knockdown of Gαq might skew the CXCR4 signaling pathway towards Gαi2. To assess the role of SHP-1 in chemotaxis we transfected Jurkat T cells with the phosphatase-deficient, mutant SHP-1 C453S (c/s) that competes with endogenous SHP-1. Cells transfected with the mutant showed significantly increased basal and CXCL12 induced migration compared to control cells indicating that an Lck-Gαq-SHP-1 pathway may regulate migration (Fig 4C). Migration is probably not exclusively regulated by SHP-1 and other negative regulators of migration activated by Gαq-kd might exist.
Figure 4
Figure 4

Migration is inhibited by activation of SHP-1. (A) Jurkat TAg T cells were transfected with Gαq-specific siRNA (GNAQ1103), Gαi2-specific siRNA (GNAI-2-1050) or control siRNA (GNAQ1103 M3). 48 hours post-transfection cells were stimulated with CXCL12 for the indicated time periods and lysed in lysis buffer. SHP-1 immunoprecipitation was performed and immune complexes analysed by immunobloting with the indicated antibodies (n = 3). (B) Immunoblots from 3 independent experiments like in (A) were quantified by densiometric analysis. The graph show mean ± S.E.M. (C) Jurkat TAg T cells were tranfected with the phosphatase defective SHP-1 c/s (C453S) mutant or empty vector. 24 hours post-transfection cells were placed in Costar Transwell plates with or without CXCL12 (10 ng/ml) and migration analysed as above. Migration index represents fold increase in migration over basal migration in wells with vector tx cells (n = 3). (D) Activation of Gαi2 induces migration through a PI3K pathway whereas activation of Gαq inhibits migration through an Lck-SHP-1 pathway priming cell for activation through the TCR.

Conclusion

We have previously shown that knockdown of Gαq attenuates TCR-induced Lck activation by an unknown mechanism [16]. While Gαi2 has a positive role in inducing migration, Gαq may have a negative regulatory role by promoting Lck activity resulting in increased SHP-1 activity (Figure 4D). Previous reports have demonstrated a reciprocal regulation between the TCR and chemokine-receptors [13, 22, 23]. Based on our recent report, an optimal TCR-triggering may require the Gαq signaling pathway as Gαq knockdown attenuates TCR-induced Lck activation [16]. In contrast, Gαq knockdown appears to release migration from tonic inhibition. This is in line with data showing increased proliferation and cytokine-production when chemokine-receptors signal through Gαq [8] suggesting that a switch from Gαi2 to Gαq through the chemokine-receptor promotes T cell activation rather than migration. In conclusion, we suggest that Gαq activation strengthens the commitment of T cells to activation through the TCR while Gαi2 activation commits the T cell to migration. This might contribute to ensure that T cells migrating towards a site of infection do not get distracted by unnecessary activation cues, while activated T cells are fully committed towards differentiation and proliferation.

Declarations

Acknowledgements

We are grateful to Gladys Tjørholm and Jorunn Solheim for technical assistance. This work was supported by grants (to Kjetil Tasken) from the Functional Genomics Programme, The Research Council of Norway, The Norwegian Cancer Society, Novo Nordic Foundation and the European Union (grant no. 037189, thera-cAMP). Jacob Ngai is a fellow of the Norwegian Cancer Society.

Authors’ Affiliations

(1)
The Biotechnology Centre of Oslo1, University of Oslo, N-0317 Oslo, Norway
(2)
Centre for Molecular Medicine, Nordic EMBL Partnership, University of Oslo, N-0317 Oslo, Norway
(3)
Institute of Immunology (IMMI), Rikshospitalet-Radiumhospitalet Medical Centre, University of Oslo, N-0027 Oslo, Norway

References

  1. Baggiolini M: Chemokines and leukocyte traffic. Nature. 1998, 392: 565-568. 10.1038/33340.View ArticlePubMedGoogle Scholar
  2. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, et al: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996, 382: 829-833. 10.1038/382829a0.View ArticlePubMedGoogle Scholar
  3. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA: A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996, 184: 1101-1109. 10.1084/jem.184.3.1101.View ArticlePubMedGoogle Scholar
  4. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, et al: Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 1998, 95: 9448-9453. 10.1073/pnas.95.16.9448.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR: Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 1998, 393: 595-599. 10.1038/31269.View ArticlePubMedGoogle Scholar
  6. Hwang IY, Park C, Kehrl JH: Impaired Trafficking of Gnai2+/- and Gnai2-/- T Lymphocytes: Implications for T Cell Movement within Lymph Nodes. J Immunol. 2007, 179: 439-448.View ArticlePubMedGoogle Scholar
  7. Shi G, Partida-Sanchez S, Misra RS, Tighe M, Borchers MT, Lee JJ, et al: Identification of an alternative G{alpha}q-dependent chemokine receptor signal transduction pathway in dendritic cells and granulocytes. J Exp Med. 2007, 204: 2705-2718. 10.1084/jem.20071267.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Molon B, Gri G, Bettella M, Gomez-Mouton C, Lanzavecchia A, Martinez A, et al: T cell costimulation by chemokine receptors. Nat Immunol. 2005, 6: 465-471. 10.1038/ni1191.View ArticlePubMedGoogle Scholar
  9. Han SB, Moratz C, Huang NN, Kelsall B, Cho H, Shi CS, et al: Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity. 2005, 22: 343-354. 10.1016/j.immuni.2005.01.017.View ArticlePubMedGoogle Scholar
  10. Huang TT, Zong Y, Dalwadi H, Chung C, Miceli MC, Spicher K, et al: TCR-mediated hyper-responsiveness of autoimmune G{alpha}i2-/- mice is an intrinsic naive CD4+ T cell disorder selective for the G{alpha}i2 subunit. Int Immunol. 2003, 15: 1359-1367. 10.1093/intimm/dxg135.View ArticlePubMedGoogle Scholar
  11. Bleul CC, Schultze JL, Springer TA: B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med. 1998, 187: 753-762. 10.1084/jem.187.5.753.PubMed CentralView ArticlePubMedGoogle Scholar
  12. Guinamard R, Signoret N, Ishiai M, Marsh M, Kurosaki T, Ravetch JV: B cell antigen receptor engagement inhibits stromal cell-derived factor (SDF)-1alpha chemotaxis and promotes protein kinase C (PKC)-induced internalization of CXCR4. J Exp Med. 1999, 189: 1461-1466. 10.1084/jem.189.9.1461.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Peacock JW, Jirik FR: TCR Activation Inhibits Chemotaxis Toward Stromal Cell-Derived Factor-1: Evidence for Reciprocal Regulation Between CXCR4 and the TCR. J Immunol. 1999, 162: 215-223.PubMedGoogle Scholar
  14. Inngjerdingen M, Rolstad B, Ryan JC: Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12. J Immunol. 2003, 171: 2889-2895.View ArticlePubMedGoogle Scholar
  15. Kumar A, Humphreys TD, Kremer KN, Bramati PS, Bradfield L, Edgar CE, et al: CXCR4 Physically Associates with the T Cell Receptor to Signal in T Cells. Immunity. 2006, 25: 213-224. 10.1016/j.immuni.2006.06.015.View ArticlePubMedGoogle Scholar
  16. Ngai J, Methi T, Andressen KW, Levy FO, Torgersen KM, Vang T, et al: The heterotrimeric G-protein alpha-subunit Galphaq regulates TCR-mediated immune responses through an Lck-dependent pathway. Eur J Immunol. 2008, 38: 3208-3218. 10.1002/eji.200838195.View ArticlePubMedGoogle Scholar
  17. Ma YC, Huang J, Ali S, Lowry W, Huang XY: Src tyrosine kinase is a novel direct effector of G proteins. Cell. 2000, 102: 635-646. 10.1016/S0092-8674(00)00086-6.View ArticlePubMedGoogle Scholar
  18. Ma YC, Huang XY: Novel regulation and function of Src tyrosine kinase. Cell Mol Life Sci. 2002, 59: 456-462. 10.1007/s00018-002-8438-2.View ArticlePubMedGoogle Scholar
  19. Ma YC, Huang XY: Identification of the binding site for Gqalpha on its effector Bruton's tyrosine kinase. PNAS. 1998, 95: 12197-12201. 10.1073/pnas.95.21.12197.PubMed CentralView ArticlePubMedGoogle Scholar
  20. Bence K, Ma W, Kozasa T, Huang XY: Direct stimulation of Bruton's tyrosine kinase by Gq-protein [alpha]-subunit. Nature. 1997, 389: 296-299. 10.1038/38520.View ArticlePubMedGoogle Scholar
  21. Inngjerdingen M, Torgersen KM, Maghazachi AA: Lck is required for stromal cell-derived factor 1alpha (CXCL12)-induced lymphoid cell chemotaxis. Blood. 2002, 99: 4318-4325. 10.1182/blood.V99.12.4318.View ArticlePubMedGoogle Scholar
  22. Zhou Z, Kim YJ, Pollok K, Hurtado J, Lee JK, Broxmeyer HE, et al: Macrophage inflammatory protein-1 alpha rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes. J Immunol. 1993, 151: 4333-4341.PubMedGoogle Scholar
  23. Johnston JA, Taub DD, Lloyd AR, Conlon K, Oppenheim JJ, Kevlin DJ: Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J Immunol. 1994, 153: 1762-1768.PubMedGoogle Scholar
  24. Methi T, Berge T, Torgersen KM, Tasken K: Reduced Cbl phosphorylation and degradation of the ζ-chain of the T cell receptor/CD3 complex in T cells with low Lck levels. Eur J Immunol. 2008, 38: 2557-63. 10.1002/eji.200737837.View ArticlePubMedGoogle Scholar
  25. Kim CH, Qu CK, Hangoc G, Cooper S, Anzai N, Feng GS, et al: Abnormal Chemokine-induced Responses of Immature and Mature Hematopoietic Cells from Motheaten Mice Implicate the Protein Tyrosine Phosphatase SHP-1 in Chemokine Responses. J Exp Med. 1999, 190: 681-690. 10.1084/jem.190.5.681.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Ngai et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

BMC Immunology

ISSN: 1471-2172

Contact us